QUANTRES ASSET MANAGEMENT Ltd boosted its holdings in shares of Danaher Co. (NYSE:DHR) by 21.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,800 shares of the conglomerate’s stock after buying an additional 1,200 shares during the period. QUANTRES ASSET MANAGEMENT Ltd’s holdings in Danaher were worth $631,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also recently modified their holdings of DHR. ETRADE Capital Management LLC boosted its stake in Danaher by 5.1% during the 2nd quarter. ETRADE Capital Management LLC now owns 19,075 shares of the conglomerate’s stock valued at $1,610,000 after purchasing an additional 917 shares during the period. Honeywell International Inc. bought a new stake in Danaher during the 2nd quarter valued at approximately $25,317,000. Roundview Capital LLC boosted its stake in Danaher by 2.0% during the 2nd quarter. Roundview Capital LLC now owns 25,674 shares of the conglomerate’s stock valued at $2,167,000 after purchasing an additional 502 shares during the period. Veritable L.P. boosted its stake in Danaher by 28.2% during the 2nd quarter. Veritable L.P. now owns 40,486 shares of the conglomerate’s stock valued at $3,417,000 after purchasing an additional 8,912 shares during the period. Finally, Wealthfront Inc. boosted its stake in Danaher by 10.2% during the 2nd quarter. Wealthfront Inc. now owns 14,574 shares of the conglomerate’s stock valued at $1,230,000 after purchasing an additional 1,348 shares during the period. 76.05% of the stock is currently owned by institutional investors.
Shares of Danaher Co. (DHR) opened at $99.39 on Friday. The company has a market capitalization of $68,579.71, a price-to-earnings ratio of 29.32, a PEG ratio of 2.14 and a beta of 1.02. Danaher Co. has a 52 week low of $78.97 and a 52 week high of $99.66. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.43 and a quick ratio of 1.00.
Danaher (NYSE:DHR) last released its earnings results on Thursday, October 19th. The conglomerate reported $1.00 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.05. Danaher had a return on equity of 11.29% and a net margin of 13.36%. The company had revenue of $4.53 billion during the quarter, compared to analysts’ expectations of $4.47 billion. During the same period last year, the firm earned $0.87 EPS. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. sell-side analysts predict that Danaher Co. will post 3.99 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be given a $0.14 dividend. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.56%. Danaher’s dividend payout ratio is currently 16.52%.
DHR has been the subject of a number of research reports. Robert W. Baird reiterated a “buy” rating and issued a $99.00 price objective on shares of Danaher in a research report on Friday, December 15th. Citigroup raised their price objective on Danaher to $107.00 and gave the stock a “buy” rating in a research report on Friday, December 15th. Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $97.00 price objective for the company in a research report on Thursday, October 5th. Cowen reiterated a “buy” rating and issued a $90.00 price objective on shares of Danaher in a research report on Wednesday, October 4th. Finally, Royal Bank of Canada restated a “hold” rating and set a $96.00 target price on shares of Danaher in a research report on Thursday, January 4th. One analyst has rated the stock with a sell rating, six have given a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $94.91.
In other Danaher news, SVP Daniel Raskas sold 37,870 shares of Danaher stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $93.33, for a total transaction of $3,534,407.10. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CFO Daniel L. Comas sold 88,184 shares of Danaher stock in a transaction dated Monday, October 23rd. The stock was sold at an average price of $91.02, for a total value of $8,026,507.68. Following the transaction, the chief financial officer now owns 227,816 shares in the company, valued at $20,735,812.32. The disclosure for this sale can be found here. Insiders sold a total of 273,810 shares of company stock worth $25,218,813 over the last 90 days. 12.20% of the stock is owned by corporate insiders.
ILLEGAL ACTIVITY NOTICE: This report was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another website, it was illegally stolen and republished in violation of U.S. & international copyright law. The correct version of this report can be read at https://www.dispatchtribunal.com/2018/01/13/quantres-asset-management-ltd-raises-stake-in-danaher-co-dhr.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.